Smart
phones and other mobile apps are largely used in various areas of
healthcare like health education, health management, data management,
health information, and relative workflow processes. Variety of
mobile phone apps have been developed to monitor the health of
patients and provide the relative data to physicians. The modern age
technology is driving the market growth as it saves time and proves
much beneficial in providing medical care to patients in remote
areas.
Healthcare
industry has exhibited the need for such innovative technologies.
Smart phones are playing a vital role in healthcare industry by
making medical services easier and even replacing some of the work
that would have previously been done on laptops or desktop computers.
Perceive the Technological
Growth Map of Mobile Medical Apps at: https://goo.gl/tnSGjV
For
a detailed study, the global mobile medical apps market is segmented
on the basis of geography, application, and product. By product, the
global mobile medical apps market is classified into iradiology, STAT
ICD-9 LITE, epocrates, Medscape mobile, nursing central, EMR apps,
care360 mobile, and netter’s atlas of human anatomy. Based on
region, the global mobile medical apps market is divided into Asia
Pacific, Europe, North America, and Rest of the World. Mobile medical
apps find application in clinical support systems, drug references,
study tools, and medical reference.
The
worldwide market for mobile medical apps is growing significantly in
developed economies like US and Europe as a significant number of
healthcare professionals are using mobile phone medical applications
in everyday business activities. Compared to other mobile phone apps
segments, there is sluggish growth in popularity of medical apps;
however, it is expected to grow rapidly in the coming few years due
to increasing dependence on medical apps for patient health
monitoring.
Some
of the key companies leading the global market for mobile medical apps are Apple Inc., Nokia, Panasonic, BlackBerry, Android, Motorola,
and Huawei.
No comments:
Post a Comment